Please use this identifier to cite or link to this item: https://doi.org/10.1038/ncomms15466
Title: Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1
Authors: Pasutto, F
Zenkel, M
Hoja, U
Berner, D
Uebe, S
Ferrazzi, F
Schödel, J
Liravi, P
Ozaki, M
Paoli, D
Frezzotti, P
Mizoguchi, T
Nakano, S
Kubota, T
Manabe, S
Salvi, E
Manunta, P
Cusi, D
Gieger, C
Wichmann, H.-E
Aung, T 
Khor, C.C 
Kruse, F.E
Reis, A
Schlötzer-Schrehardt, U
Keywords: complementary DNA
DNA
genomic DNA
hepatocyte nuclear factor 4
hepatocyte nuclear factor 4alpha
heterodimer
immunoglobulin enhancer binding protein
immunoglobulin G
lysyl oxidase like 1
messenger RNA
myogenin
nf 1 protein
NR2F1 protein
oligonucleotide
peroxisome proliferator activated receptor alpha
peroxisome proliferator activated receptor gamma
protein
puromycin
retinoic acid
retinoid X receptor alpha
RNA polymerase II
roaz protein
small interfering RNA
transcription factor
unclassified drug
zid protein
LOXL1 protein, human
oxidoreductase
protein binding
retinoid X receptor alpha
allele
cardiovascular disease
chemical binding
data assimilation
enzyme activity
genetic variation
protein
risk factor
allelic imbalance
alternative RNA splicing
Article
binding affinity
binding site
biotinylation
chromosome 15
cohort analysis
comparative study
controlled study
DNA binding
DNA probe
DNA protein complex
enhancer region
gel mobility shift assay
gene activation
gene control
gene expression
gene locus
genetic transfection
genetic variability
genetic variation
genome-wide association study
genotype
genotype phenotype correlation
glaucoma
haplotype
human
human tissue
in vitro study
intron
luciferase assay
major clinical study
molecular size
nonsense mediated mRNA decay
polymorphic locus
promoter region
protein binding
protein expression
pseudoexfoliation
quantitative analysis
reverse transcription polymerase chain reaction
RNA analysis
single nucleotide polymorphism
steady state
transient transfection
upregulation
aged
allele
case control study
chemistry
chromatin
complication
female
genetic predisposition
genetics
Germany
Italy
Japan
male
middle aged
pseudoexfoliation
very elderly
Aged
Aged, 80 and over
Alleles
Alternative Splicing
Amino Acid Oxidoreductases
Case-Control Studies
Chromatin
Enhancer Elements, Genetic
Exfoliation Syndrome
Female
Genetic Predisposition to Disease
Genome-Wide Association Study
Genotype
Germany
Glaucoma
Humans
Introns
Italy
Japan
Male
Middle Aged
Polymorphism, Single Nucleotide
Protein Binding
Retinoid X Receptor alpha
Issue Date: 2017
Publisher: Nature Publishing Group
Citation: Pasutto, F, Zenkel, M, Hoja, U, Berner, D, Uebe, S, Ferrazzi, F, Schödel, J, Liravi, P, Ozaki, M, Paoli, D, Frezzotti, P, Mizoguchi, T, Nakano, S, Kubota, T, Manabe, S, Salvi, E, Manunta, P, Cusi, D, Gieger, C, Wichmann, H.-E, Aung, T, Khor, C.C, Kruse, F.E, Reis, A, Schlötzer-Schrehardt, U (2017). Pseudoexfoliation syndrome-associated genetic variants affect transcription factor binding and alternative splicing of LOXL1. Nature Communications 8 : 15466. ScholarBank@NUS Repository. https://doi.org/10.1038/ncomms15466
Rights: Attribution 4.0 International
Abstract: Although lysyl oxidase-like 1 (LOXL1) is known as the principal genetic risk factor for pseudoexfoliation (PEX) syndrome, a major cause of glaucoma and cardiovascular complications, no functional variants have been identified to date. Here, we conduct a genome-wide association scan on 771 German PEX patients and 1,350 controls, followed by independent testing of associated variants in Italian and Japanese data sets. We focus on a 3.5-kb four-component polymorphic locus positioned spanning introns 1 and 2 of LOXL1 with enhancer-like chromatin features. We find that the rs11638944:C>G transversion exerts a cis-acting effect on the expression levels of LOXL1, mediated by differential binding of the transcription factor RXR? (retinoid X receptor alpha) and by modulating alternative splicing of LOXL1, eventually leading to reduced levels of LOXL1 mRNA in cells and tissues of risk allele carriers. These findings uncover a functional mechanism by which common noncoding variants influence LOXL1 expression. © The Author(s) 2017.
Source Title: Nature Communications
URI: https://scholarbank.nus.edu.sg/handle/10635/179715
ISSN: 2041-1723
DOI: 10.1038/ncomms15466
Rights: Attribution 4.0 International
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1038_ncomms15466.pdf1.39 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons